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3Definitions of some terms used in this technical brief
Children are people below the age of 18 years, unless, under the law applicable to the child, majority is attained earlier.(1) 
Adolescents are people aged 10–19 years.(2) 
Young people are those aged 10–24 years.(3) 
“Young people who inject drugs” in this document refers to people 10–24 years of age who inject non-medically 
sanctioned psychotropic (or psychoactive) substances, including children 10–17 years and adults 18–24 years.
While this technical brief uses age categories currently employed by the United Nations and the World Health Organization 
(WHO), it is acknowledged that the rate of physical and emotional maturation of young people varies widely within each 
category.(4) The United Nations Convention on the Rights of the Child recognizes the concept of the evolving capacities of 
the child, stating in Article 5 that direction and guidance, provided by parents or others with responsibility for the child, 
must take into account the capacities of the child to exercise rights on his or her own behalf. 
Key populations are defined groups who due to specific higher-risk behaviours are at increased risk of HIV, irrespective 
of the epidemic type or local context. They often have legal and social issues related to their behaviours that increase their 
vulnerability to HIV. The five key populations are men who have sex with men, people who inject drugs, people in prisons 
and other closed settings, sex workers, and transgender people.(5)
People who inject drugs refers to people who inject non-medically sanctioned psychotropic (or psychoactive) substances. 
These drugs include, but are not limited to, opioids, amphetamine-type stimulants, cocaine, hypno-sedatives and 
hallucinogens. Injection may be through intravenous, intramuscular, subcutaneous or other injectable routes. 
This definition of injecting drug use does not include people who self-inject medicines for medical purposes, referred to as 
“therapeutic injection”, nor individuals who self-inject non-psychotropic substances, such as steroids or other hormones, 
for body shaping or for improving athletic performance. 
GLOSSARY
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INTRODUCTION
Young people aged 10–24 years constitute one-quarter 
of the world’s population,(6) and they are among 
those most affected by the global epidemic of human 
immunodeficiency virus (HIV). In 2013, an estimated 4.96 
million people aged 10–24 years were living with HIV, and 
young people aged 15–24 years accounted for an estimated 
35% of all new infections worldwide in people over 15 
years of age.(7) 
Key populations at higher risk of HIV include people who 
sell sex, men who have sex with men, transgender people 
and people who inject drugs. Young people who belong 
to one or more of these key populations – or who engage 
in activities associated with these populations – are made 
especially vulnerable to HIV by widespread criminalisation, 
discrimination, stigma and violence, combined with the 
particular vulnerabilities of youth, power imbalances in 
relationships and, sometimes, alienation from family and 
friends. These factors increase the risk that they may 
engage – willingly or not – in behaviours that put them 
at risk of HIV, such as frequent unprotected sex and the 
sharing of needles and syringes to inject drugs. 
Governments have a legal obligation to respect, protect 
and fulfil the rights of children to life, health and 
development, and indeed, societies share an ethical duty 
to ensure this for all young people. This includes taking 
steps to lower their risk of acquiring HIV, while developing 
and strengthening protective systems to reduce their 
vulnerability. However, in many cases, young people from 
key populations are made more vulnerable by policies 
and laws that demean, criminalize or penalize them or 
their behaviours and by education and health systems 
that ignore or reject them and that fail to provide the 
information and treatment they need to keep themselves 
safe. 
The global response to HIV largely neglects young key 
populations. Governments and donors fail to adequately 
fund research, prevention, treatment and care for them. HIV 
service-providers are often poorly equipped to serve young 
key populations, while the staff of programmes for young 
people may lack the sensitivity, skills and knowledge to 
work specifically with members of key populations. 
 
According to joint estimates by the United Nations Office 
on Drugs and Crime, the World Health Organization (WHO) 
and the Joint United Nations Programme on HIV/AIDS 
(UNAIDS), an estimated 12.7 million (8.9 million-22.4 
million) people globally inject drugs,(8) around 80% of 
whom live in low- and middle-income countries.(9) The age 
distribution is not known. The continued high prevalence 
of injecting drug use, combined with insufficient coverage 
of harm-reduction programmes, is of concern because 
of the strong association of unsafe injecting with risk 
for transmission of HIV and other infections such as 
viral hepatitis.(10,11) Although global coverage of harm-
reduction services has slowly increased, there is a lack 
of services focused on and accessible to young people, 
despite low ages of initiation into injecting drug use in 
many countries and important differences in vulnerability 
and risk between younger and older people who inject 
drugs. Consequently, young people who inject drugs 
find it difficult to obtain information, sterile injecting 
Although global coverage of 
harmreduction services has slowly 
increased, there is a lack of 
services focused on and accessible 
to young people, despite low ages 
of initiation into injecting drug use 
in many countries and important 
differences in vulnerability and 
risk between younger and older 
people who inject drugs.
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5Community consultations: the voices, values and needs of young people
• An important way to better understand the needs and challenges of young key populations is to listen to their own 
experiences. This technical brief draws upon insights from the research and advocacy of young people who inject 
drugs. It also incorporates information from consultations organized in 2013 in six regions by Youth RISE, a global 
youth-led harm-reduction network, with the support of UNAIDS;(12) and consultations organized in 2013 by the United 
Nations Population Fund in collaboration with organizations working with young key populations, including young 
people who inject drugs, in eastern Europe and southeast Africa.(13) Since these were small studies, the findings are 
intended to be illustrative rather than general. Representative quotations or paraphrases from participants in the 
consultations are included so that their voices are heard.
• Where participants in the consultations were children, appropriate consent procedures were followed.
equipment, drug dependence treatment, including 
methadone treatment for opioid dependence, and HIV 
testing, counselling and treatment. Age restrictions or 
requirements for parental consent can also make services 
less accessible. Programmes are frequently not designed to 
respond to the overlapping vulnerabilities of young people 
who inject drugs or the specific legal challenges and ethical 
concerns in working with children. These vulnerabilities 
require responses that may go beyond the harm-reduction 
programmes recognized as effective for adults. 
This technical brief is one in a series addressing four young 
key populations. It is intended for policy-makers, donors, 
service-planners, service-providers and community-led 
organizations. This brief aims to catalyse and inform 
discussions about how best to provide health services, 
programmes and support for young people who inject 
drugs. It offers a concise account of current knowledge 
concerning the HIV risk and vulnerability of young people 
who inject drugs; the barriers and constraints they face 
to appropriate services; examples of programmes that 
may work well in addressing their needs and rights; and 
approaches and considerations for providing services that 
both draw upon and build the strengths, competencies and 
capacities of young people who inject drugs.
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YOUNG PEOPLE WHO INJECT DRUGS
There is a critical need for more comprehensive age-
disaggregated data, particularly in developing country 
contexts, on young people who inject drugs, ecological 
factors which contribute to injecting drug use, their levels 
of risk for HIV and other illnesses, and their protective 
behaviours. Current methods of gathering and reporting 
data make it impossible to calculate a reliable global 
estimate of the number of young people who inject drugs.
(14) Fewer than a quarter of the countries reporting in the 
2010 United Nations General Assembly Special Session on 
Drugs provided age-disaggregated data on people under 
the age of 25 years who inject drugs.(15) There are several 
reasons for this. In some countries there is simply no 
reliable data on drug use among young people in general. 
The criminalization and stigmatization of drug use in most 
countries forces many young people to hide their drug use. 
Legal constraints and ethical concerns make it difficult 
to recruit children for studies, and the great majority of 
research therefore excludes participants under 18 years of 
age.(16) Older survey participants do not always accurately 
recall the age at which they began injecting drugs, and 
rapid changes in drug-using practices may in any case 
make their information out of date.(17) Girls and young 
women are also underrepresented in surveys of injecting 
drug use. Harm-reduction services can serve as important 
mechanisms for data collection,(18) but the lack of such 
services, and age restrictions placed upon them, limit the 
amount of data they provide on young people.  
For some young people, drug use is a part of adolescent 
experimentation, risk-taking and reward seeking, 
particularly in the presence of peers. On the other hand, 
some participants in the consultations with young people 
who inject drugs identified negative experiences that 
spurred them to begin using – and eventually injecting 
– drugs: feelings of alienation, anger or emptiness, or 
difficulties with their families.(20) Various studies have 
demonstrated that children who have experienced 
adversity, including neglect and physical, sexual, and 
emotional abuse, are more likely to use drugs – including 
injecting drugs.(21,22) Such evidence has important 
implications for policies and programmes that aim to 
reduce the initiation of young people into drug use, as well 
as those that provide health care and protection services to 
young people who inject drugs.
In the community consultation with young people who 
inject drugs, it was noted that there was a progression 
from smoking drugs to snorting them and then to injecting. 
Reasons for beginning to inject ranged from curiosity and 
the desire to get a more intense high, to a wish to use 
drugs more “efficiently” or to counteract the decreasing 
Harm Reduction
• Harm reduction refers to policies, programmes and practices that aim primarily to reduce the adverse health, social 
and economic consequences of the use of licit and illicit drugs. The harm-reduction approach is based on a strong 
commitment to public health and human rights, and targets the causes of risks and harms. Harm reduction helps 
protect people from preventable health harms and death from overdose, and helps connect marginalized people with 
other social and health services. The UN system has endorsed a core package of nine essential harm-reduction services 
for people who inject drugs which have been shown to reduce HIV infections:(19)
1. Needle and syringe programmes (NSPs)
2. Opioid substitution therapy (OST) and other evidence-based drug dependence treatment
3. HIV testing and counselling (HTC)
4. Antiretroviral therapy (ART)
5. Prevention and treatment of sexually transmitted infections (STIs)
6. Condom programmes for people who inject drugs and their sexual partners
7. Targeted information, education and communication (IEC) for people who inject drugs and their sexual partners
8. Prevention, vaccination, diagnosis and treatment for viral hepatitis
9. Prevention, diagnosis and treatment of tuberculosis (TB).
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7quality and potency of their drugs. The desire to belong to 
a group and participate in its activities is natural among 
young people, and it may be particularly strong for those 
whose social ties are otherwise precarious. Socializing 
with young people who inject drugs also normalizes and 
reinforces injecting behaviour.(23) 
“The drugs fill the emptiness of losing a father or a mother, or so you seem to feel.” 
Young man, Mexico(24)
Some countries, such as Pakistan, Russian Federation and 
Viet Nam, have reported increases in the prevalence of 
injecting drug use among young people.(25) In Central and 
Eastern Europe an estimated 1 out of every 4 people who 
inject drugs is under 20 years of age.(26) Whatever their 
motivation for drug use or for injecting, many people who 
inject drugs report that they began injecting in adolescence. 
In the consultations most said this occurred between 
the ages of 15 and 18 years,(27) but in some countries 
initiation takes place at a younger age: in a study among 
young people (aged 10–19 years) living or working on the 
streets in four cities of Ukraine, 45% of those who reported 
injecting drugs said that they began doing so before they 
were 15 years old,(28) while in an Albanian study, one-third 
of people who inject drugs aged 15–24 years had begun 
before the age of 15.(29) 
The frequency with which young people inject varies, and 
they may not have developed dependence or experienced 
adverse consequences for their health. For these reasons, 
many of them may not identify as a “person who injects 
drugs” or see themselves as needing any guidance or 
treatment. This has important implications for the design 
of programmes to reach and support young people who 
inject drugs. Young people who inject drugs and who have 
overlapping vulnerabilities, such as homelessness, living or 
working on the street, or economic marginalization, may 
consider these to be more pressing concerns.  
In 2013, an estimated 1.7 million (range: 0.9 million to 4.8 
million) people who injected drugs worldwide were living 
with HIV. This represents a global HIV prevalence of 13.1% 
among all people who inject drugs aged 15–64 years.(30) 
There are few data about HIV prevalence among young 
people who inject drugs, but what is known is of concern: 
• In a 2011 study in Dar es Salaam, United Republic of 
Tanzania, 25.6% of a sample of young people aged 
17–25 years who injected heroin were living with HIV.
(31)
• A 2010 survey of street youth across multiple cities in 
Ukraine found that one-third of those aged 15–17 years 
who injected drugs were living with HIV.(32) 
• Among street youth aged 15–19 years in St Petersburg, 
Russian Federation, who injected drugs, HIV prevalence 
was 79% in 2007.(33) 
A significant proportion of young people who inject drugs 
become infected with HIV within the first 12 months of 
initiation.(34,35) In Ho Chi Minh City, Viet Nam, 24% 
of people who inject drugs under 25 years had started 
injecting within the previous 12 months, and of these, 28% 
were infected with HIV.(36)
People who inject drugs have the highest risk of hepatitis 
C virus (HCV) infection of any key population.(37) Globally, 
around 10 million people who inject drugs, or 67% percent 
of the estimated global total of people who inject drugs, 
are infected with HCV, and an estimated 1.2 million (8.4%) 
with hepatitis B virus (HBV).(38) Some studies have reported 
much higher incidence of both HBV and HCV than HIV 
among people who inject drugs, and data suggest that 
HBV prevalence may be higher among younger people who 
inject.(39,40)
• A baseline study in Hanoi, Viet Nam, found that 28.3% 
of young people who inject heroin aged 15–19 years 
were HCV positive.(41) 
• Among people who inject drugs aged 18–24 years in 
Sarajevo, Bosnia and Herzegovina (42) and in Serbia,(43) 
baseline HCV prevalence was found to be 36.0% and 
47.6% respectively.
• Among people who inject drugs aged 18–30 years in a 
neighbourhood of New York City, USA, HCV prevalence 
was 51%.(44) 
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HIV RISK AND VULNERABILITY 
Compared to their age peers in the wider population, and 
to older people who inject drugs, young people who inject 
drugs are more vulnerable to HIV. This is due to specific risk 
behaviours – sharing non-sterile injecting equipment, and 
unprotected sex – which are linked to numerous individual, 
interpersonal and structural factors. 
Sharing non-sterile injecting equipment
Exposure to HIV through use of contaminated injecting 
equipment is six times more likely to result in infection 
than exposure through unprotected vaginal intercourse.
(45) Many adolescents’ first experience of injecting involves 
being given drugs by a friend, peer, sexual partner or 
other person and sharing their used injecting equipment.
(46,47) Young people who inject drugs often do so in groups 
and are more likely to share equipment than their older 
counterparts, especially where rituals develop around 
injecting in social networks.(48,49) Such practices may 
involve the young person being last to use the equipment. 
In Indonesia, for example, 52% of young people who 
inject drugs aged 15–19 years, surveyed in 2007 and 2009, 
shared needles. This figure dropped to roughly one in three 
among those aged 20–24 years.(50) This situation is further 
compounded by the low coverage of needle and syringe 
exchange programmes in low and middle income countries, 
criminalization of drug use and stigma and discrimination 
directed at people who inject drugs.(51)
Sharing equipment for the preparation of drugs is a 
common behaviour among young people who inject 
drugs, and it is an additional risk factor for transmission 
of HCV.(52,53) In a study of people who inject drugs aged 
15–30 years in five US cities, those who reported sharing 
equipment (cottons, cookers, rinse water) to prepare drugs 
for injection had a threefold increase in the risk of HCV 
sero-conversion.(54)
Unprotected sex
Injecting drug use often occurs in the context of 
overlapping risks for HIV, such as sexual intercourse 
without the use of a condom. Factors including the young 
person’s knowledge and their ability to gauge risk can 
influence choices to have unprotected sex. In addition, 
the use of certain substances – including alcohol – may 
increase sexual desire or lower behavioural inhibitions, 
further affecting risk perception. Apart from sexual contact 
with intimate partners, some young people may also 
exchange sex for drugs1, or to obtain money for drugs, or 
may be at risk of sexual abuse. 
“The main concern of young people who use drugs is their drugs. They do not think about diseases and 
have sex without protection.” 
Young person, Mauritius(55) 
Changes during adolescence
Adolescence is a period of rapid physical, psychological, 
sexual, emotional and social change. For some young 
people, drug use, like sex, is a way of experimenting 
with new forms of socialization, pleasure-seeking and 
risk taking. The development of the brain in adolescence 
influences the individual’s ability to balance immediate and 
longer-term rewards and goals, and to accurately gauge 
risks and consequences.(56,57) This can make adolescents 
more vulnerable due to risk taking, peer pressure, or other 
social factors , and therefore potentially to HIV infection.
Ypung people who inject drugs are more likely than older 
people to lack knowledge about safer injecting practices 
and HIV prevention, and to be unaware of risks to their 
health. Many young participants in the consultations 
reported that when they began injecting drugs as young 
people they were unconcerned about HIV, other STIs, viral 
hepatitis or tuberculosis.(58) Young people who inject drugs 
are also more likely than older people to be isolated from 
harm-reduction services, and to be unable to afford to buy 
injecting equipment.(59,60) In addition, criminalization of 
drug use and stigma and discrimination directed at people 
who inject drugs(57) increase their vulnerability to HIV.
(61,62) 
Social marginalization and discrimination
In many regions, injecting drug use is most prevalent 
among socially marginalized young people, including those 
who are from dysfunctional family environments, out of 
school, living in extreme poverty, or living or working on 
the streets.(63) Each of these factors can contribute to a 
context of emotional or social disruption in which drugs 
may be both attractive and available, and where there are 
fewer deterrents to experimenting with them. 
• In Albania, over one-quarter of males aged 15–24 years 
1 In this series of technical briefs, the term “young people who sell sex” refers to 
people 10-24 years of age, including children 10-17 years who are sexually exploited 
and adults 18-24 years who are sex workers. For further information, please see HIV 
and young people who sell sex: A technical brief (Geneva: WHO, 2014).
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school, and 30% were homeless.(64)
• A multi-city assessment of street youth in Ukraine (aged 
15–24 years) found that nearly 1 in 5 was HIV-infected, 
with prevalence considerably higher among those who 
injected drugs (42%) and highest among those who 
shared needles(49%).(65)
• In a 2007 survey of children aged 12–17 years living or 
working on the streets in Greater Cairo and Alexandria, 
Egypt, over half were currently using drugs, and 3% 
reported injecting. Only 5% were currently in school.(66)
Drug use is criminalised and highly stigmatized in nearly 
all countries, and social, familial and religious disapproval 
can lead to stigma and discrimination against people who 
use drugs, further isolating them from health care systems.  
Young people who inject drugs are more vulnerable to 
these negative consequences because they tend to depend 
on family or educational institutions for support, guidance, 
care, protection, food, housing and other resources. In 
particular, children who inject drugs may be living with 
parents or guardians who do not fulfil their responsibilities, 
rights or duties to care for, protect, or provide them with 
appropriate direction and guidance, which may incite them 
to leave home or spend a considerable amount of time 
on the streets. Spending large amounts of time on the 
streets increases the chances that young people who inject 
drugs will interact with others engaging in risky injecting 
practices and higher-risk sexual behaviours, including older 
adults more likely to be infected with HIV. The social and 
economic isolation of young people who inject drugs only 
increases the likelihood that non-sterile injecting equipment 
will be used.(67)
“I was expelled from school and abandoned by my own family when they found out I was taking some 
[non-injecting] drugs. So I thought, Why not go all 
the way?” 
Young person, Indonesia(68)
Racial and ethnic marginalization
In some regions, injecting drug use is disproportionately 
prevalent among young members of ethnic minorities. A 
study in Bucharest, Romania, found that more than one-
quarter of young people aged 10–24 years who injected 
drugs were Roma, a proportion three times higher than 
their proportion of the general population.(69) Among 
young people who inject drugs aged 13–19 years diagnosed 
with HIV in the United States in 2011, 61.7% were 
African American and 21.3% Latino, far higher than their 
proportion of the overall population.(70) More research 
is needed to understand the reason for these disparities, 
though it has been suggested that the social isolation and 
discrimination suffered by some ethnic-minority youth 
may be linked to drug and alcohol use, lack of easy access 
to health services, and lack of knowledge about HIV 
prevention.(71)
Young women
Increased risk of injecting has also been noted among 
young women, who have additional vulnerabilities to HIV 
infection compared to their male peers who inject drugs.
(72,73) Consultations in Nepal and Nigeria with groups of 
young women who inject drugs indicated that many rely 
on their male partners to provide injecting equipment, and 
they are consequently less likely than young men to access 
harm-reduction services.(74) They reported frequent sharing 
of syringes with their male partners and, in Nigeria, “flash 
blooding” – a technique of injecting oneself with blood 
extracted from another person who has recently injected a 
drug, usually heroin.(75)
“When I was first introduced to injecting by my boyfriend I never knew anywhere to get needles 
because he was the one who used to inject me. So 
this was a major challenge for me.”
Young woman, Kenya(76)
Young women may also be more concerned than their male 
counterparts about being exposed as people who inject 
drugs because they face even stronger stigmatization.(77)
Young women who inject drugs in Kyrgyzstan said that 
sexual and reproductive health services were important to 
them, but they felt stigmatized when accessing them.(78)
Pregnant women who inject drugs are less likely than non-
injecting pregnant women to have access to antenatal care 
and prevention of mother-to-child transmission services, 
thus increasing the risk of passing infection to their new-
borns.(79)
“It’s harder for females to seek help, get tested [for STIs], or even talk about it.” 
Young woman, Lebanon(80)
Sexual exploitation/selling of sex
Young people who inject drugs have multiple vulnerabilities 
and risk to HIV. Some young people exchange sex for 
drugs, or to obtain money for drugs,(81,82,83,84,85) and this 
may make them less likely to turn down a transaction or to 
insist that a client use a condom, thus increasing their risk 
of contracting HIV or another STI. They are also at risk of 
violence, including rape.
15220-HIV and young people who inject drugs-topic 27-Version 2 Folder.indd   9 05/10/2015   08:41
HIV and young people who inject drugs: A technical brief10
LEGAL AND POLICY CONSTRAINTS
The United Nations Convention on the Rights of the 
Child (CRC, 1989) is an international treaty that obliges 
States parties to protect the rights of all people under 18 
years of age, with an emphasis on the principles of four 
guiding principles of the best interests of the child; non-
discrimination; the right to life, survival and development; 
and respect for the views of the child (see Annex 1).(86) 
With regard to the latter principle, it is important to note 
that the Committee on the Rights of the Child, in General 
Comment No. 4, stated that this principle is fundamental 
to implementing the right to health and development of 
adolescents. Public authorities, parents and other adults 
working with or for children, must create an environment 
that is based on “trust, information sharing, capacity 
to listen and sound guidance” which facilitates the 
participation of adolescents in decision-making. In addition, 
the CRC also recognizes the important concept of children’s 
evolving capacities (Articles 5 and 14), stating in Article 5 
that States parties must respect the “responsibilities, rights 
and duties” of parents (or other persons legally responsible 
for the child) to provide appropriate direction and guidance, 
taking into account the capacities of the child to exercise 
rights on his or her own behalf.  
International human-rights law is clear on the obligation 
of States parties to protect children from the illicit use 
of narcotic drugs and psychotropic substances, provide 
evidence-based and human-rights-compliant harm 
reduction, HIV prevention and drug dependence treatment 
programmes.(87) In practice, however, the access of 
young people who inject drugs to information and harm-
reduction services is affected by significant legal and policy 
constraints, including weak implementation of the law by 
justice and law enforcement officials, and the rights of 
children  to life and health under the CRC are contravened 
when they are excluded from effective HIV prevention and 
life-saving treatment, care and support services.
Criminalization
Laws criminalizing use or possession of drugs or of injecting 
equipment can deter people from seeking services because 
of their fear of arrest and prosecution. These laws may 
deter harm-reduction service-providers from offering 
assistance including because of concerns about their own 
legal liability.(88) Criminalization of drug use also reduces 
the future employment prospects of those who have been 
convicted and can lead to financial instability.  
Police harassment and violence
Young people who inject drugs may be targeted by the 
police for arrest or extortion, and carrying a needle or 
syringe may be taken as evidence of drug use, which is a 
disincentive to seek services such as needle and syringe 
programmes (NSPs).(89) NSP sites themselves may be 
targeted by police as a location to harass or arrest young 
people who inject drugs. Young people who exchange sex 
for drugs or to obtain money for drugs are also vulnerable 
to arrest or harassment by police.(90,91,92) 
“Of course police choose those who are young [to arrest], and we know that police are always present 
in such places [NSPs].” 
Young woman, Kyrgyzstan(93)
Arrest, detention and imprisonment are considerable 
risks for young people who use drugs, despite the fact 
that Article 37 of the CRC specifies that such acts “shall 
be in conformity with the law and shall be used only as 
a measure of last resort and for the shortest appropriate 
period of time”.(94) The detention and forced treatment 
of young people who inject drugs is also a human-rights 
violation and public health concern, because access to 
rights-based and evidence-informed harm-reduction 
measures in places of detention is usually limited or non-
existent. In addition, risk behaviours for HIV and hepatitis 
are more prevalent in such settings, and incarcerated 
young people are particularly at risk of sexual abuse by 
older prisoners.(95) Human-rights violations in so-called 
drug detention or rehabilitation centres are now well 
documented, leading the UN system, including the World 
Health Organization, to call for these centres to be closed 
down.(96)
Legal minority status
For those under the legal age of majority, access to 
harm-reduction services is more complicated. Child 
protection laws and policies that aim to protect children 
from significant harm, as well as mandatory reporting 
requirements for particular professions, must be taken into 
account when designing and implementing programmes for 
children who inject drugs. 
Access to services may be legally restricted. For those 
below the legal age of majority, access to NSPs is often 
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limited because of stigma, marginalization and law 
enforcement practices, which account for the reluctance of 
young people who inject drugs to carry syringes and adopt 
dangerous drug storage and concealment methods.(57). Age 
restrictions exist for NSPs in 18 of 77 countries surveyed 
by Harm Reduction International in 2012, showing that 
while such restrictions are not the norm, they still present 
an important barrier.(97) A more common scenario is where 
the legal and policy situation is unclear or not sufficiently 
supportive. This is a considerable gap considering the 
widespread moral or ethical concerns among service-
providers themselves about how to appropriately intervene 
with young people who use drugs, especially children, and 
fears about being seen to condone or facilitate drug use.
Opioid substitution therapy (OST) to treat opiate 
dependency is far less common among children 10–17 
years than among adults, partly because many children 
who inject do not use opiates, and also because in many 
cases if dependency develops, most are of an age to fall 
under adult treatment protocols for OST. Nevertheless, in 
at least 29 of the 74 countries where OST is available, age 
restrictions are placed upon it. This hinders clinicians from 
making decisions in the best interests of the individual 
client.(98)
Even in countries with no legal age restrictions, other 
requirements, such as mandatory parent/guardian consent 
requirements, or evidence of previous failed attempts at 
detoxification or other drug treatment modalities, may limit 
or complicate the access of children 10–17 years to crucial 
harm-reduction services.(99)
“[Under-18s] can go [to harm-reduction services], but only with their parents – their father or someone 
who is over 18 must go with them. They cannot go 
by themselves.”
Young person, Mexico(100)
Policy and research
At a broader policy level, attitudes towards drug use 
influence what research is funded and what questions 
are asked. When the only political goal is to reduce drug 
use overall among young people, research tends to focus 
on lifetime prevalence of drug use among this age group, 
rather than drug-related harms among those that use 
drugs.(101) Straightforward “don’t do drugs” messaging 
may be politically popular, but is ineffective in changing the 
behaviour of vulnerable young people(102,103) and obscures 
the need for research into preventing harm for those who 
do use and inject drugs.
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SERVICE COVERAGE AND BARRIERS TO ACCESS
Funding of programmes for young people who inject 
drugs is inadequate, despite their disproportionate risk 
of acquiring HIV. A 2010 systematic review found that 
worldwide coverage of HIV prevention, treatment and 
care services for all people who inject drugs, although 
increasing, is still very low.(104) 
Need for additional services for young 
people
While the harm-reduction approach has been proven to 
reduce HIV infections among people who inject drugs, as 
a rule such programmes are not designed with the specific 
needs and vulnerabilities of young people in mind. In 
addition to the core package of harm-reduction services and 
overdose prevention, many young people who inject drugs 
also require age-appropriate medical and mental health 
services, child and family welfare services, housing, food, 
legal assistance, social protection benefits, and access to 
education, vocational training or employment opportunities.  
Lack of youth-friendly and youth-focused 
services and programmes
Most services specific to people who inject drugs, such as 
NSPs, are designed for adults and do not operate in a way 
that is engaging, appropriate or friendly to young people. 
Many young people do not like to access services alongside 
adult clients because they feel they have little in common 
with them, or feel unsafe around them. Service-providers 
often lack the skills or knowledge to work with vulnerable 
young people. Furthermore, unless outreach is directed 
specifically at young people who inject drugs through their 
social networks and the media they use, they are unlikely 
to be aware that services exist.
Young people want information
“Lack of information is the biggest problem when you are young. You don’t know where to turn for 
syringes.” 
Young man, Slovenia(105)
“Some of my brothers got HIV infected, and they wanted to take treatment but did not know how. 
We heard that we had to pay as well. I didn’t 
know who and how to help. I didn’t know any peer 
outreach workers to get consulted and get access 
to treatment.”
Young person, Viet Nam(106)
“When my parents found out that I was doing drugs they chased me onto the streets in order to 
keep me away, but I rather wanted some advice, 
such as not to share needles. They wanted me to 
stop. But they do not have access to information 
about drugs.” 
Young woman, Romania(107)
“You have to inform people to help them make educated decisions. It’s the only way you’re going to 
help people make positive decisions in their lives – 
by giving them factual information.”
Young man, USA(108)
Parent/guardian consent
Many participants in the Youth RISE consultations reported 
that even when services are available, they prefer to 
obtain needles from pharmacies, in part because of parent/
guardian consent requirements for minors to access NSPs, 
or the need for an official ID, which some children may not 
possess.(109) Pharmacies are less than ideal as a source of 
needles and syringes because most do not provide a full 
harm-reduction package or links to other services. Although 
some parents wish to actively support their children in 
seeking harm-reduction services, some young people who 
inject drugs express concerns about age restrictions and 
requirements for parental consent for OST, as well as the 
fear that by registering for OST, their drug use might be 
made public.(110)
“Nobody wants to start on methadone at 18 because [...] you will have no normal life after 
that, no driving licence, and they will give out data 
on you everywhere, at school, local police and to 
doctors.” 
Young person, Kyrgyzstan(111)
Stigma and discrimination by service-
providers
Negative experiences with health services – such as 
judgemental attitudes of providers, the inability to treat 
young people respectfully or the perception of lack of 
privacy and confidentiality – discourage young people who 
inject drugs from seeking the services they need. In some 
countries, a conservative social climate makes it harder 
for young people, especially females, to access sexual and 
reproductive health services.
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“What ends up happening if you do end up being [HIV] positive? How could you deal with the stigma 
of that?” 
Young man, USA(112)
Lack of integrated services and 
insufficient capacity
Separate services for TB, HIV, viral hepatitis and other 
aspects of harm reduction, as well as for sexual and 
reproductive health, make it difficult for young people 
who inject drugs to access care. Services that address the 
non-medical needs of vulnerable youth beyond drug use 
are also frequently not integrated, and existing services 
may be poorly equipped to deal with the needs and rights 
of young people who inject drugs. Child welfare and 
protection services - which are responsible for ensuring 
that the holistic needs and rights of children are met 
and that they have access to a range of information and 
services across care, protection, health justice, education 
and employment sectors – frequently lack both financial 
and human resources. Social workers working within child 
protection systems also often have insufficient training on 
how to work with children who inject drugs in a manner 
that fulfils their best interests, or lack the time to spend 
with child clients who inject drugs due to large caseloads 
and competing demands.
Poor access to HIV testing and treatment
Access to antiretroviral therapy (ART) by people who 
inject drugs is disproportionately low compared with 
other key populations at higher risk of HIV – particularly 
in low- and middle-income countries – and remains 
restricted by systemic and structural barriers. For example, 
people who inject drugs comprise 67% of cumulative HIV 
cases in China, Malaysia, Russian Federation, Ukraine 
and Viet Nam, but make up only 25% of ART recipients.
(113) Where ART is available, regular drug use can 
make adherence difficult,(114) but other factors such as 
homelessness also make adherence to care and treatment 
in general harder to maintain.
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SERVICES AND PROGRAMMES ADDRESSING THE 
NEEDS AND RIGHTS OF YOUNG PEOPLE WHO 
INJECT DRUGS 
Around the world, programmes for and with young people 
who inject drugs are being implemented by governments, 
civil-society organizations and by organizations of 
people who use drugs. Relatively few have been fully or 
independently evaluated, but the elements of a number 
of promising programmes are presented briefly here, as 
examples of how the challenges in serving young people 
who inject drugs may be addressed. These examples are 
illustrative and not prescriptive. They may not be adaptable 
to all situations, but they may inspire policy-makers, 
donors, programme-planners and community members to 
think about effective approaches to programming in their 
own contexts.
Reaching young people through a drop-in centre
Kimara Peer Educators and Health Promoters Trust Fund (Kimara Peers), United Republic of Tanzania
• Kimara Peers, a community-based NGO in a low-income area of Dar es Salaam, opened a drop-in centre (DIC) to 
provide outreach and services to people who inject or otherwise use drugs, including those aged 16–24 years. The DIC 
is near a government-run health centre and dispensary. It is open between 8 a.m. and 4 p.m. and serves people who 
inject drugs as well as young people who sell sex, since there is an overlap between the two populations. 
• Services offered at the DIC include individual and group psychosocial therapy and support, basic information on harm 
reduction, HIV/AIDS, viral hepatitis and other STIs, and information on condom use. Referrals are made for methadone-
assisted therapy and treatment of STIs. Education and materials designed for young people on sexual and reproductive 
health, including HIV, are available. Referrals to government hospitals are made only with the young person’s consent, 
and confidentiality is maintained unless the young person gives permission for their parents or other family members 
to be informed. Government approval is being sought for provision of clean needles and syringes upon request at the 
DIC and by outreach workers.  
• Services are offered by Kimara Peers staff, including trained community outreach workers from the local area and a 
professional social worker. Outreach workers publicise the DIC when they are working in the community, as well as at 
public events such as for World Drugs Day.
 Website: http://142.177.80.139/kimara/ 
In their own words: What young people say they are 
looking for in service delivery 
“We want a safe place with a warm response and a happy face.” 
Young man, Indonesia
“A place to visit without any fear, with staff that care about your soul.” 
Young woman, Ukraine
“It is easier if [outreach workers] are your friends and you do the same [kinds of things] with them 
and […] you can say this and that to them.”
Young person, Nigeria
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Increasing the uptake of harm-reduction services through an incentives programme
STOP AIDS, Albania 
• STOP AIDS, an NGO in Tirana, implemented an incentives programme with a group of young people who inject drugs 
to assess whether small incentives could motivate reduction in higher-risk behaviours associated with drug use and 
increase alternative or less risky behaviours. These included getting clean needles and returning used ones, being 
tested for HIV, bringing new clients to the programme, and allowing home visits by STOP AIDS staff. 
• For six months, vouchers and coupons were used as incentives, redeemable for a variety of retail goods such as pre-
paid phone cards, food, fuel, clothing and haircuts. Vouchers were accumulated in a clinic-managed bank account and 
distributed to clients once a week. The standard reward for participants ranged from 1 point (equivalent to US $1) for 
receiving harm-reduction kits, to 5 points for those who introduced a new client to the programme. 
• The programme was successful in significantly improving clients’ attendance and uptake of some harm-reduction 
services, especially the needle and syringe programme, HIV and hepatitis testing, as well as introducing new clients 
and sexual and injecting female partners to the programme, compared to a control group who did not participate 
in the programme. More than half of the clients introduced programme staff to their family members and allowed 
home visits or counselling. However, voucher incentives seemed less effective for changing certain behaviours such 
as returning used needles, switching from injecting drugs to non-injecting behaviours or compliance with opioid 
substitution therapy. Further study is needed to determine the sustainability of health-seeking behaviour change 
through incentives.  
 Website: www.facebook.com/stopaids.albania
Building the capacity of local programmes 
Youth RISE (Resource, Information, Support, Education), Asia-Pacific Region 
• Youth RISE, an international youth-led network promoting evidence-based drug policies and harm-reduction strategies, 
was asked to help a community-based organization in Indonesia that was having difficulty engaging young people 
in services. A member of the Youth RISE leadership and an Indonesian Youth RISE member conducted a week-long 
consultation with the programme staff. One of the barriers identified was the perception that youth programmes 
should aim to prevent drug use rather than providing harm-reduction services to young people. Through reflection and 
discussion, staff decided that a harm-reduction approach was indeed necessary to protect the health and well-being of 
young people.  
• Focus group discussions with young people who use drugs identified barriers to services such as not knowing about 
the programme because of lack of targeted outreach; a strong programme focus on injecting drug use, even though 
many young people did not inject consistently or at all; feeling intimidated or bullied by older users; and a perception 
that drug services would attempt to dissuade young people from using drugs. 
• The programme developed a strategic plan to engage young people with relevant services and activities. This included 
a shift from targeting young people in schools to engaging with those living or working on the streets. The programme 
focus was widened to include non-injecting drug use and amphetamine-type stimulants. Recreational activities such 
as sports were organized, as well as educational workshops on sexual health and drug-related harm reduction. 
The programme also provided support around life skills, economic issues, legal issues and police harassment. The 
programme now engages 70 young people directly in regular activities, with outreach to more young people in the 
community by peer educators. 
 Website: www.youthrise.org
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Disseminating information via multiple channels 
Programa de Política de Drogas (Espolea, A.C), Mexico 
• Espolea, a youth-led organization in Mexico City, opened a Drug Policy and Harm Reduction Programme in 2008 and 
has developed online and face-to-face channels to provide objective information about drugs and risk reduction to 
young people aged 15–29 years. 
• The organization has found that information is most effective when disseminated at places where young people use 
drugs, particularly electronic dance music festivals, rock concerts and cultural gatherings. Espolea sets up a stand 
as a safe space for young people to access information about drugs that may be consumed at these events. The 
organization also facilitates workshops in schools and in communities with concentrations of most-at-risk young 
people. 
• Espolea has an active outreach strategy through social media, including Facebook and Twitter, as well as blogs on a 
variety of programmes and topics. One blog (www.universodelasdrogas.org) serves as a databank on drugs and has 
become the axis of the programme’s harm-reduction campaign. Information is produced by staff and collaborators, 
and by other young actors in the region. Printed materials are also a part of outreach and include attractive designs 
and useful information, facts and recommendations about nightlife, alcohol consumption, risky sexual behaviours, HIV 
and other STIs. 
 Website: www.espolrea.org
Engagement of young key populations in responding to HIV and sexual and reproductive 
health issues 
Fokus Muda, Indonesia 
• Fokus Muda aims to promote the meaningful involvement of young key populations in the HIV and broader sexual 
health and rights response in Indonesia. The programme brings together young people aged 15–27 years for advocacy, 
capacity-building and technical assistance and to help them be effective leaders in representing young people’s issues 
and securing rights for themselves. 
• To develop an advocacy toolkit for use by young key populations at the local level, the programme conducted 
extensive consultations and capacity-building with young people who inject drugs, young people who sell sex, young 
MSM, young transgender people, and young people living with HIV from 11 provinces with high HIV prevalence. 
Capacity-building sessions were held separately because of the differences between the profiles and interests of the 
various key populations. Each participant represented a local community-based organization and had been actively 
engaged with their community for at least one year. An additional national consultation meeting for young key 
population members was held.
• Participants were encouraged to identify the issues of greatest concern for them. For young people who inject drugs, 
the issues were the lack of specific programmes for them countrywide and of relevant harm-reduction programming. 
Outcomes and recommendations from the consultations were fed back to the participants and to other stakeholders, 
and formed part of the data used in advocacy about the government’s 2015-2019 National Strategic Plan on AIDS. 
 Website: www.fokusmuda.wordpress.com 
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APPROACHES AND CONSIDERATIONS FOR 
SERVICES 
A. CONSIDERATIONS FOR 
PROGRAMMES AND SERVICE 
DELIVERY 
In the absence of extensive research on specific 
programmes for young people who inject drugs, a 
combination of approaches can be extrapolated from 
health programmes deemed effective for young people or 
for key populations in general. It is essential that services 
are designed and delivered to take into account the 
differing needs and rights of young people who inject drugs 
according to their age, specific behaviours, the complexities 
of their social and legal environment and the epidemic 
setting. The below considerations are largely focused on 
health programmes for young people who inject drugs, 
but may also be relevant to other programme types, such 
as welfare, protection, care, justice, education and social 
protection.
1) Overarching considerations for services 
for young people who inject drugs 
• Acknowledge and build upon the strengths, 
competencies and evolving capacities of young people 
who inject drugs, especially their ability to express their 
views and articulate what services they need. 
• Promote the best interests of young people who inject 
drugs, including prioritization of access to effective 
HIV and health services, including harm-reduction 
programmes and voluntary, evidence-based treatment 
for drug dependence, rather than the arrest, detention or 
imprisonment of young people who inject drugs.
• Involve young people who inject drugs meaningfully 
in the planning, design, implementation, monitoring 
and evaluation of services suited to their needs in local 
contexts.
• Fully utilize existing infrastructure and services that have 
been demonstrated to be appropriate and effective, e.g., 
services for youth, and ensure improved coverage and 
access for young people who inject drugs.
• Ensure that health, welfare, protection, education, 
and social protection programmes and services are 
integrated, linked and multidisciplinary in nature, 
with a strong system for referral and the continuum 
of care, in in order to utilize the most comprehensive 
range of services possible and address the overlapping 
vulnerabilities and intersecting behaviours of different 
key populations.
• Ensure that there is sufficient capacity amongst 
professionals, particularly health workers, social 
workers and law enforcement officials, to work with 
young people who inject drugs and apply rights-based 
approaches and evidence-informed practice.
• Partner with community-led organizations of youth and 
people who inject drugs, building upon their experience 
and credibility with young people who inject drugs. 
• Build robust baselines, monitoring and evaluation into 
programmes to strengthen quality and effectiveness, and 
develop a culture of learning, evidence based practice 
and willingness to adjust programmes accordingly.
• Give primary consideration to the best interests of the 
child in the design and delivery of all programmes and 
services for children who inject drugs in accordance 
with the CRC (Annex 1) and other relevant international 
treaties, including HIV and sexual and reproductive 
health services.(1) 
2) Implement a comprehensive health 
package1 
For young people who inject drugs, and which is sensitive 
to the rights of children, as recommended in the WHO 
Consolidated guidelines on HIV prevention, diagnosis, 
treatment and care for key populations: (116) 
• Harm reduction, in particular provision of sterile 
injecting equipment through needle and syringe 
programmes, opioid substitution therapy for those 
who are dependent on opioids, and other evidence-
based drug dependence treatment, and access to 
naloxone for emergency management of suspected 
opioid overdose. It is important that countries 
where injecting drug use occurs prioritize immediate 
implementation of NSPs and OST. Implementation of 
1 This package is essentially the same as the comprehensive health package for HIV 
prevention, treatment and care for people who inject drugs that has been widely 
endorsed at the highest political level and by major donor agencies  (WHO, 2009; 
2012).
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these essential harm-reduction services should facilitate 
and enhance access to HIV-specific services, such as HIV 
testing and counselling and antiretroviral therapy, and 
improve adherence to treatment. 
• HIV prevention including condoms with condom-
compatible lubricants, post-exposure prophylaxis, and 
voluntary medical male circumcision for heterosexual 
men in hyper endemic and generalized HIV epidemics.
• Voluntary HIV testing and counsellingin community 
and clinical settings, with linkages to prevention, care 
and treatment services.
• HIV treatment and care including antiretroviral 
therapy and management including access to services for 
prevention of mother-to-child transmission.
• Prevention and management of co-infections and 
co-morbidities including prevention, screening and 
treatment for tuberculosis and hepatitis B and C. 
• Routine screening and management of mental-health 
disorders, including evidence-based programmes for 
those with harmful alcohol or other substance use.
• Sexual and reproductive health including access 
to screening, diagnosis and treatment of sexually 
transmitted infections, a range of contraceptive options, 
services related to conception and pregnancy care, 
cervical cancer screening and abortion, and services that 
protect health and human rights. 
3) Make programmes and services 
accessible, acceptable and affordable for 
young people
• Offer community-based, decentralized services, through 
mobile, outreach and at fixed locations, with particular 
attention to young women who inject drugs.(4)
• Ensure that service locations are easy and safe for young 
people who inject drugs to access.(117)
• Integrate services within other programme settings such 
as youth health services, drop-in centres,(4) shelters, and 
youth community centres. 
• Promote mobile Health staffed by trained operators, 
counsellors, and young people themselves, to provide 
developmentally appropriate health and welfare 
information to young people who inject drugs, as well 
as the opportunity for referrals to relevant services.
(118,119,120) 
• Provide developmentally appropriate information and 
education for young people who inject drugs and their 
partners, focusing on skills-based risk reduction and 
disseminated via multiple media, including online, 
mobile phone technology and participatory approaches.
(66,121)
• Provide information and services through peer-based 
initiatives, which can also help young people find 
appropriate role models. Ensure appropriate training, 
support and mentoring to help young people who inject 
drugs advocate within their communities to support 
them in accessing services.(122)
• Ensure that young people who inject drugs have access 
to health and HIV prevention information, regardless 
of their marital status and whether their parents/
guardians consent,(123) and that medical treatment 
without parental/guardian consent is possible and 
effectively considered when in the best interests of 
the individual.  Develop or strengthen protection and 
welfare services that help parents and families to fulfil 
their responsibilities to effectively protect, care for 
and support young people who inject drugs, and in the 
case of children who inject drugs aim to reintegrate 
the children with their families, if in their individual 
best interests, or provide other appropriate living 
arrangements and care options in line with the 2010 UN 
Guidelines for Alternative Care.(124)
• Provide services at times convenient to young people 
who inject drugs and make them free of charge or low-
cost.(66)
• Ensure that services are non-coercive, respectful and 
non-stigmatizing, that young people who inject drugs 
are aware of their rights to confidentiality and that any 
limits of confidentiality are made clear(3,4) by those with 
mandatory reporting responsibilities.
• Train health-care providers on the health needs and 
rights of young people who inject drugs, as well as 
relevant overlapping vulnerabilities such as sexual 
exploitation/selling of sex.(3) 
4) Address the additional needs and 
rights of young people who inject drugs, 
including:
• Primary health-care services including services for 
survivors of violence, including physical, emotional and 
sexual violence. 
15220-HIV and young people who inject drugs-topic 27-Version 2 Folder.indd   18 05/10/2015   08:41
19
• Immediate shelter and long-term accommodation 
arrangements, as appropriate, including independent 
living and group housing.    
• Food security, including nutritional assessments.
• Livelihood development and economic strengthening, 
and support to access social services and benefits. 
• Support for young people who inject drugs to remain in 
or access education or vocational training, and foster 
opportunities to return to school for out-of-school young 
people.
• Psychosocial support thorough therapy, counselling, peer 
support groups and networks, to address the impact 
of stigma, discrimination, and social exclusion, or to 
address mental-health issues (66).
• Available counselling for families, including parents of 
young people who inject drugs – where appropriate and 
requested – to support and facilitate access to services, 
especially where parent/guardian consent is required (11).
• Access to free or affordable legal information and 
services for advocacy and assistance, including 
information for young people who inject drugs about 
their rights, reporting mechanisms and access to legal 
redress (69).
• Services for those in prison or detention,(69) including 
police cells, prisons, juvenile detention centres, 
immigrant detention centres, and closed rehabilitation 
shelters.
B. CONSIDERATIONS FOR LAW AND 
POLICY REFORM, RESEARCH AND 
FUNDING 
1) Supportive laws and policies regarding 
young people who inject drugs
• Apply a rights-based, public-health and harm-reduction 
approach to drug use.(54)
• Work for the decriminalization of drug use, and for the 
implementation and enforcement of anti-discrimination 
and protective laws, based on human-rights standards, 
to eliminate stigma, discrimination, social exclusion and 
violence against young people who inject drugs based 
on actual or presumed behaviours and HIV status.(125)
• In the context of children, uphold laws, administrative, 
social and educational measures to protect children 
from illicit use of narcotic drugs and other psychotropic 
substances as stipulated in the CRC (Annex 1) and 
defined in the relevant international treaties. Change 
law enforcement procedures so they do not allow the 
confiscation of needles and syringes for use as evidence 
of drug use for criminal charges or other penalties.(126) 
• Work toward the immediate closure of compulsory 
detention and rehabilitation centres.(59) 
• Prevent and address violence against young people 
who inject drugs1, in partnership with organizations 
led by people who use drugs, as appropriate. All 
acts of violence and harmful treatment – including 
harassment, discriminatory application of public order 
laws and extortion2 – by law enforcement officials 
should be monitored and reported, redress mechanisms 
established,(4,69) and disciplinary measures taken. 
• Examine current consent policies to consider removing 
age-related barriers and parent/guardian consent 
requirements that impede access to HIV and STI testing, 
treatment and care.(3) Address social norms around 
drug use through education with adolescents in schools, 
using evidence-based methods to build social skills 
and decision-making capacities, delivered by health 
professionals and peer.(127)
• Include relevant programming specific to the needs 
and rights of young people who inject drugs in national 
health plans and policy, with linkages to other relevant 
plans and policies, such as those pertaining to the child 
protection and education sectors.
1 Protect children from all forms of sexual exploitation and sexual abuse, 
criminalizing all forms of sexual exploitation including the offering, obtaining 
procuring and providing of children for sexual exploitation, in line with 
international law.
2 Ensure that the rights of children survivors and witnesses are safeguarded and that 
children are exempted from arrest and prosecution. Children should be treated as 
survivors and not as offenders, and not be placed in unlawful or arbitrary detention, 
and be  designated with an appropriate legal guardian or other recognized 
responsible adult or competent public body when identified or placed in any shelter 
or other care facility
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2) Strategic information and research, 
including: 
• Population size, demographics and epidemiology, with 
disaggregation of behavioural data and HIV, STI and viral 
hepatitis prevalence by age group and sex.1 
• Evaluate the effectiveness of programmes addressing 
young people who inject drugs, including services 
offered by organizations led by people who use drugs, 
rehabilitation interventions, and community and family-
based support and reintegration services.
• Research on the structural factors that impact drug 
use, and the impact of laws and policies upon access to 
health and other services.(69)
• Involvement of young people who inject drugs, including 
children 10–17 years, in research activities in a safe 
and ethical manner to ensure that they are appropriate, 
acceptable and relevant from the community’s 
perspective.  
1 In some circumstances, determining population size estimates or mapping key 
populations can have the unintended negative consequence of putting community 
members at risk for violence and stigma by identifying these populations and 
identifying where they are located. When undertaking such exercises, it is 
important to ensure the safety and security of community members by involving 
them in the design and implementation of the exercise. This is especially important 
with regards to children, who are particularly vulnerable to abuse, neglect, violence 
and exploitation. For more information see Guidelines on Estimating the Size of 
Populations Most at Risk to HIV by the UNAIDS/WHO Working Group on Global HIV/
AIDS and STI Surveillance (Geneva: World Health Organization, 2010).
3) Funding 
• Increase funding for research, implementation and scale-
up of initiatives addressing young people who inject 
drugs.   
• Ensure that there is dedicated funding in national plans 
for HIV, and child protection for programmes that target 
young people who inject drugs, and other programmes 
that address overlapping vulnerabilities.
• Recognize overlapping vulnerabilities of key populations 
in funding and delivery of services.
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ANNEX 1. THE UNITED NATIONS CONVENTION ON 
THE RIGHTS OF THE CHILD (1989)
The Convention on the Rights of the Child (CRC) is the most 
widely and rapidly ratified human rights treaty in history. 
Ratification of the CRC signifies an agreement by the 
State to be legally bound by the terms of the Convention, 
to undertake “all appropriate legislative, administrative 
and other measures” for the full realization of the rights 
it contains, and to report on these measures to the 
Committee on the Rights of the Child.
While children have the same general human rights as 
adults, the CRC enshrines additional rights for children out 
of recognition that children (people under 18 years of age) 
require unique forms of care and protection that adults 
do not.(128) The CRC has four guiding principles, which 
represent the underlying requirements for any and all rights 
to be realized. These are: non-discrimination (Article 2), 
with the Convention applying to all children everywhere; 
the best interests of the child (Article 3), which must be a 
primary consideration in all actions concerning children; the 
right to life, survival and development (Article 6), in order 
that they can survive and reach their full potential; and 
respect for the views of the child (Article 12), recognizing 
that children have the right to express their views and have 
them taken into account according to their age and level of 
maturity.  
Like all human rights, child rights are indivisible and 
interrelated, meaning that the CRC places an equal 
emphasis on all rights for children, that no hierarchy of 
rights exists, and that the deprivation of one right adversely 
affects the others. However, in relation to children at 
particular risk of HIV, there are particular rights that 
deserve special mention. The right to health, as articulated 
in Article 24, obligates States parties to ensure that no child 
is deprived of his or her right of access to necessary health 
services, stressing “the right of the child to the enjoyment 
of the highest attainable standard of health and to facilities 
for treatment of illness and rehabilitation of health”. The 
Committee on the Rights of the Child General Comment 
No. 4 on Adolescent health and development in the context 
of the Convention on the Rights of the Child highlights 
that Article 2, on the right to enjoy all rights without 
discrimination, “also cover adolescent’s sexual orientation 
and health status (including HIV/AIDS and mental health).” 
The Committee further notes that all adolescents who are 
discriminated against are more vulnerable to violence and 
exploitation, and that their health and development are 
placed at further risk.
Further, General Comment No. 3 on HIV/AIDS and the 
Rights of the Child emphasizes that effective HIV/AIDS 
prevention requires States to refrain from censoring, 
withholding or intentionally misrepresenting health-related 
information, including sexual education and information, 
and that, consistent with their obligations to ensure the 
right to life, survival and development of the child (Article 
6), States parties must ensure that children have the ability 
to acquire the knowledge and skills to protect themselves 
and others as they begin to express their sexuality. The 
Committee also points out that children are more likely to 
use services that are friendly, supportive, wide-ranging, 
geared toward their needs, give them the opportunity 
to participate in decisions affecting their health, are 
accessible, affordable, confidential, non-judgmental, do not 
require parental consent and are non-discriminatory.
There are also particular rights that should be underscored 
in the context of children who inject drugs, with the CRC 
being the only core UN human rights treaty that specifically 
refers to drug use. Article 33 requires that States parties 
“shall take all appropriate measures, including legislative, 
administrative, social and educational measures, to 
protect children from the illicit use of narcotic drugs 
and psychotropic substances as defined in the relevant 
international treaties…” In relation to the particular 
vulnerabilities of children who abuse substances to HIV, the 
Committee on the Rights of the Child has pointed out in 
General Comment No. 3 that, consistent with both Articles 
33 and 24, States parties must ensure the implementation 
of programmes that reduce the factors that expose children 
to the use of substances, but also provide treatment and 
support to children who use substances.  
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